Elite Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
$254K Sell
4,271
-960
-18% -$56.1K 0.41% 36
2016
Q2
$287K Sell
5,231
-503
-9% -$26.8K 0.47% 34
2016
Q1
$289K Buy
5,734
+774
+16% +$37.9K 0.41% 33
2015
Q4
$249K Buy
+4,960
New +$250K 0.37% 36
2015
Q1
Sell
-10,255
Closed -$555K 69
2014
Q4
$555K Sell
10,255
-472
-4% -$26.3K 0.53% 41
2014
Q3
$607K Sell
10,727
-2,590
-19% -$145K 0.55% 37
2014
Q2
$735K Sell
13,317
-4,503
-25% -$246K 0.73% 37
2014
Q1
$965K Sell
17,820
-4,902
-22% -$254K 0.78% 35
2013
Q4
$1.08M Buy
22,722
+20,823
+1,097% +$952K 0.79% 32
2013
Q3
$86K Buy
1,899
+746
+65% +$34.1K 0.08% 130
2013
Q2
$51K Buy
+1,153
New +$51.5K 0.08% 122

Other funds holding MRK

Elite Wealth Management's MRK Position: Q3 2016 in Review

Elite Wealth Management reduced its Merck (MRK) stake by 18% in Q3 2016, selling an estimated $56.1K and leaving 4,271 shares worth $254K. The position accounts for 0.41% of the portfolio, ranked #36.

Elite Wealth Management first reported a position in MRK in Q2 2013 and has held it in 11 quarters since. The position peaked at $1.08M in Q4 2013. 1,814 funds tracked by Wall St. Rank hold MRK as of Q3 2016.

  • Elite Wealth Management held 4,271 shares of Merck worth $254K as of Q3 2016.
  • Elite Wealth Management sold 960 Merck shares in Q3 2016, an estimated $56.1K.
  • Merck made up 0.41% of Elite Wealth Management's portfolio in Q3 2016, its #36 holding.
  • Elite Wealth Management first reported a position in Merck in Q2 2013 and has held it in 11 quarters since.
  • Elite Wealth Management's Merck position peaked at $1.08M in Q4 2013.
  • 1,814 funds tracked by Wall St. Rank held Merck as of Q3 2016.

Based on Elite Wealth Management's 13F filing for Q3 2016, filed 23 Nov 2016.